Search results

Selected filters:

Analysis
Life Sciences

Article type

Topic

Sector

Regions

Year

305 results found for your search

Sort options
21 January 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade

16 January 2020

What IP owners need to know about the US-China trade deal

There are significant gains for branded pharma in the agreement. But in several other areas, China has made commitments it already meets

16 January 2020

Viability of sham litigation suits on the line in AbbVie appeal

The award of $448 million in antitrust damages against the company in case brought by the Federal Trade Commission is also at stake.

15 January 2020

Updated: Broad Institute faces tough fight in CRISPR patent appeal hearing

Oral hearings before the EPO’s Boards of Appeal may have a big impact on the European Cas9 landscape

13 January 2020

After SCOTUS denies cert in high profile 101 cases focus moves back to Congress

Decision not to hear Athena dispute will disappoint many, but may prove catalyst to reinvigorate stalled efforts to reform US patent eligibility regime

10 January 2020

Everything you need to know about 2019 US district court patent litigation

Apple top defendant again; Eastern District of Texas loses further ground; and other key stats

10 January 2020

In case against Apple, more evidence of the IP hazards of convergence

Medtech leader Masimo accuses tech giant of patent infringement and trade secret theft

09 January 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases

08 January 2020

Increasing scrutiny for patent filing subsidies in China

Last year patent agencies came under scrutiny for gaming the system, and corporate IP managers say they expect tighter auditing in the year to come

07 January 2020

Google brief in Oracle fight kicks off what could be a big six months for IP at SCOTUS

Search giant claims Fed Circuit ruling threatens interconnected software ecosystem, while three 101 cases also on Supreme Court’s radar in big term for rights owners

07 January 2020

Federal Circuit delivers good news for process patent owners

A precedential decision last month makes it easier for rights holders to assert successfully against imported products

02 January 2020

The most important Asia IP developments you missed over the holiday season

Impending US-China deal, a big Supreme Court ruling in India and a new licensing programme from Toyota are among the regional highlights

20 December 2019

Jury awards $752 million in dispute over cutting-edge CAR-T technology

The California case was one of the early patent battles over the breakthrough cancer cell therapy technology, which is set to become a crowded space in years to come.

19 December 2019

Oblon McClelland Maier & Neustadt revealed as number one filer for the IAM/ktMINE US Patent Elite

Arlington-based firm acts for more of the companies that own the biggest US portfolios than any other, with Foley & Lardner and Harness Dickey & Pierce rounding out the top three

17 December 2019

We are working with pharma companies better than ever before, says top university patent dealmaker

In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions